Rita K. Kuwahara, MD, MIH Today marks a historic day. The CMS’ selection of 10 critical medicines eligible for drug price negotiation sets off the process that will allow Medicare, for the first time, to negotiate prices of a small subset of prescription medicines directly with drug manufacturers.

Source:www.healio.com
Original Image Link

Source:www.healio.com
Original Image Link